Publications by authors named "Matthew Heeney"

Claim this Profile
A
A xeno-free red blood cell differentiation formula models sickle cell disease from somatically sourced patient iPSCs.
Ashlee J Conway, Tolulope O Rosanwo, Thomas E Williamson, Samuel Landry, Melissa A Kinney, Matthew M Heeney

Exp Hematol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The GLYT1 inhibitor bitopertin mitigates erythroid PPIX production and liver disease in erythroid protoporphyria.
Sarah Ducamp, Min Wu, Juan Putra, Dean R Campagna, Yi Xiang, Matthew M Heeney

J Clin Invest· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
X
X-linked sideroblastic anemia in females.
Sarah Ducamp, Dean R Campagna, Anoop K Sendamarai, Paul J Schmidt, Harrison K Tsai, Matthew M Heeney

Blood· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of Genetic Mutation With Outcomes in Children With Hereditary Spherocytosis Undergoing Partial Splenectomy: A Multicentre Study.
Joshua K Ramjist, Tamara Dubljevic, Eveline Lapidus-Krol, Rachael F Grace, Matthew M Heeney

J Pediatr Surg· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screen of the ReFRAME Compound Library for Therapeutic Agents to Prevent Red Blood Cell Sickling Using an Improved High Throughput Sickling Assay.
Akito Nakagawa, Kaycie Morwood, Kristen Johnson, Lorenzo Berra, Lauren Boal, Matthew M Heeney

ACS Omega· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained increase in annual transcranial Doppler screening rates in children with sickle cell disease: A quality improvement project.
Jeffrey G Edwards, Adam P Yan, Ramy Yim, Mo Oni, Matthew M Heeney

Pediatr Blood Cancer· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain.
Emily M Harris, Morohuntodun O Oni, Carolina Donado, Matthew M Heeney, Jean Solodiuk

J Pediatr Hematol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increasing COVID-19 Vaccination Rates for Children With Sickle Cell Disease.
Adam P Yan, Natasha M Archer, Dianne Arnold, Eileen Hansbury, Matthew M Heeney

Pediatrics· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Controlled Analgesia for Vaso-Occlusive Episodes in Children: A Retrospective Study.
Carolina Donado, Emily M Harris, Matthew M Heeney, Jean C Solodiuk, Christine D Greco

J Pain Symptom Manage· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine use for management of vaso-occlusive pain in pediatric sickle cell disease.
Emily M Harris, Emily Vilk, Carolina Donado, Alexis Williams, Matthew M Heeney

Pediatr Blood Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus definition of essential, optimal, and suggested components of a pediatric sickle cell disease center.
Monica L Hulbert, Deepa Manwani, Emily Riehm Meier, Ofelia A Alvarez, R Clark Brown, Matthew M Heeney

Pediatr Blood Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
Matthew M Heeney, Miguel R Abboud, Jessie Githanga, Baba P D Inusa, Julie Kanter

Blood· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sickle Cell Disease and Gene Therapy - Patient and Physician Perspectives.
Michael DeBaun, Matthew Heeney, Terry Jackson, Dan Longo, Melesa Love

N Engl J Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-Throughput Assay to Screen Small Molecules for Their Ability to Prevent Sickling of Red Blood Cells.
Akito Nakagawa, Marissa K Cooper, Maria Kost-Alimova, James Berstler, Binglan Yu, Matthew M Heeney

ACS Omega· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardizing Opioid Prescribing in a Pediatric Hospital: A Quality Improvement Effort.
Carolina Donado, Jean C Solodiuk, Susan T Mahan, Rachel L Difazio, Matthew M Heeney

Hosp Pediatr· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and Predictors of Iron Deficiency in Adolescent and Young Adult Outpatients: Implications for Screening.
Rose Eiduson, Matthew M Heeney, Pei-Chi Kao, Wendy B London, Mark D Fleming

Clin Pediatr (Phila)· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.
Matthew M Heeney, Simon Berhe, Dean R Campagna, Joseph H Oved, Peter Kurre

Hum Mutat· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Belzutifan, a Potent HIF2α Inhibitor, in the Pacak-Zhuang Syndrome.
Junne Kamihara, Kayla V Hamilton, Jessica A Pollard, Catherine M Clinton, Jill A Madden, Matthew M Heeney

N Engl J Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of ketamine for the management of vaso-occlusive pain in sickle cell disease.
Emily M Harris, Emily Vilk, Matthew M Heeney, Jean Solodiuk, Christine Greco

Pediatr Blood Cancer· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Transcriptional Genetic Silencing of to Treat Sickle Cell Disease.
Erica B Esrick, Leslie E Lehmann, Alessandra Biffi, Maureen Achebe, Christian Brendel, Matthew M Heeney

N Engl J Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydroxyurea Optimization through Precision Study (HOPS): study protocol for a randomized, multicenter trial in children with sickle cell anemia.
Emily R Meier, Susan E Creary, Matthew M Heeney, Min Dong, Abena O Appiah-Kubi

Trials· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutations in the iron-sulfur cluster biogenesis protein HSCB cause congenital sideroblastic anemia.
Andrew Crispin, Chaoshe Guo, Caiyong Chen, Dean R Campagna, Paul J Schmidt, Matthew M Heeney

J Clin Invest· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biochemical and therapeutic effects of Omega-3 fatty acids in sickle cell disease.
Ahmed A Daak, Miguel A Lopez-Toledano, Matthew M Heeney

Complement Ther Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An emerging role for endothelial barrier support therapy for congenital disorders of glycosylation.
William J Brucker, Stacy E Croteau, John R Prensner, Kate Cullion, Matthew M Heeney

J Inherit Metab Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic Differences in Phenotype and Treatment of Children with Sickle Cell Anemia from the Multinational DOVE Study.
Baba Psalm Duniya Inusa, Raffaella Colombatti, David C Rees, Matthew M Heeney, Carolyn C Hoppe

J Clin Med· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis